Author:
Niederle N.,Weidmann B.,Budach V.,Schirren J.
Publisher
Springer Berlin Heidelberg
Reference83 articles.
1. Aisner J, Whitacre M, Echo DA van, Fuks JZ (1984) Cyclophosphamide, doxorubicin and etoposide (CAE) for the treatment of small cell lung cancer. In: Issel BF, Muggia FM, Carter SK (eds) Etoposide (VP-16). Current status and new developments. Academic Press, New York, pp 171–182
2. Alba E, Breton JJ, Alonso L, Paredes G, Belon J, Ballesteros P (1992) Alternating chemotherapy for small-cell lung cancer. A twelve-week schedule of six drugs. Ann Oncol 3: 31–35
3. Allan SG, Gregor A, Cornbleet MA, Leonard RCF, Smyth JF, Grant IWB, Crompton GK (1984) Phase II trial of vindesine and VP 16 in the palliation of poor-prognosis patients and elderly patients with small cell lung cancer. Cancer Chemother Pharmacol 13: 106–108
4. Ambrosone CB, Rao U, Michalek AM, Cummings KM, Mettlin CJ (1993) Lung cancer histologic types and family history of cancer. Analysis of histologic subtypes of 872 patients with primary lung cancer. Cancer 72: 1192–1198
5. Arriagada R, Le Chevalier Th, Baldeyrou P, Pico JL, Ruffle P, Martin M, El Bakry HM, Duroux P, Bignon J, Lenfant B, Hayat M, Rouesse JG, Sancho-Garnier H, Tubiana M (1985) Alternating radiotherapy and chemotherapy schedules in small cell lung cancer, limited disease. Int J Radiat Oncol Biol Phys 11: 1461–1467
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献